Correlation Between Eli Lilly and C4 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and C4 Therapeutics, you can compare the effects of market volatilities on Eli Lilly and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and C4 Therapeutics.

Diversification Opportunities for Eli Lilly and C4 Therapeutics

EliCCCCDiversified AwayEliCCCCDiversified Away100%
-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Eli and CCCC is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Eli Lilly i.e., Eli Lilly and C4 Therapeutics go up and down completely randomly.

Pair Corralation between Eli Lilly and C4 Therapeutics

Considering the 90-day investment horizon Eli Lilly and is expected to generate 0.46 times more return on investment than C4 Therapeutics. However, Eli Lilly and is 2.16 times less risky than C4 Therapeutics. It trades about 0.37 of its potential returns per unit of risk. C4 Therapeutics is currently generating about -0.38 per unit of risk. If you would invest  80,678  in Eli Lilly and on November 27, 2024 and sell it today you would earn a total of  9,502  from holding Eli Lilly and or generate 11.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Eli Lilly and  vs.  C4 Therapeutics

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -20-10010
JavaScript chart by amCharts 3.21.15LLY CCCC
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly sluggish essential indicators, Eli Lilly showed solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb750800850900
C4 Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb33.544.55

Eli Lilly and C4 Therapeutics Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-5.7-4.27-2.84-1.410.02561.543.084.626.15 0.020.040.060.080.100.12
JavaScript chart by amCharts 3.21.15LLY CCCC
       Returns  

Pair Trading with Eli Lilly and C4 Therapeutics

The main advantage of trading using opposite Eli Lilly and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.
The idea behind Eli Lilly and and C4 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Content Syndication
Quickly integrate customizable finance content to your own investment portal